Clinical Trial Update: Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study [NA]

View source ↗

Summary

This clinical trial update states that CapsuleX combined with cisplatin for platinum-resistant recurrent ovarian cancer is currently recruiting in a single-arm …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Platinum-resistant Recurrent Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CapsuleX

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Recurrent Ovarian Cancer, Platinum Resistance | NA | Status: RECRUITING